Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

Introduction: RTS,S/AS01 is currently the most advanced malaria vaccine but provides incomplete, short-term protection. It was developed for use within the expanded program on immunizations (EPI) for African children. Another use could be adding mass RTS,S/AS01 vaccination to the integrated malaria...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: von Seidlein, Lorenz, Hanboonkunupakarn, Borimas, Jittamala, Podjanee, Pongsuwan, Pongphaya, Chotivanich, Kesinee, Tarning, Joel, Hoglund, Richard M., Winterberg, Markus, Mukaka, Mavuto, Peerawaranun, Pimnara, Sirithiranont, Pasathorn, Doran, Zoe, Ockenhouse, Christian F., Ivinson, Karen, Lee, Cynthia, Birkett, Ashley J., Kaslow, David C., Singhasivanon, Pratap, Day, Nicholas P.J., Dondorp, Arjen M., White, Nicholas J., Pukrittayakamee, Sasithon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2019
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012096/
https://ncbi.nlm.nih.gov/pubmed/31306084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1643675
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi